Skip to content

Ovarian cysts and homoeopathic management

Management of ovarian cysts through homoeopathic individualized medicines in women of reproductive age group - A prospective open label observational study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/05/086244
Enrollment
60
Registered
2025-05-05
Start date
Unknown
Completion date
Unknown
Last updated
2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N831- Corpus luteum cyst Health Condition 2: N830- Follicular cyst of ovary Health Condition 3: N832- Other and unspecified ovarian cysts

Interventions

Intervention1: Nil: Nil

Sponsors

CCRH
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Women of age group 18-45 years presenting with symptoms of ovarian cyst or carrying USG reports with them indicating ovarian cyst. ii. Women who are already taking allopathic / alternative system medicines will be enrolled after at least 1 month as washout period.

Exclusion criteria

Exclusion criteria: i. Simple (Follicular/ Luteal cyst) of size less than 4 cm ii. Complex cyst of size more than 10 cm iii. History of hyperprolactinemia iv. Ovarian tumor or CA 125 levels above 35 U/ml v. HE 4(human epididymis protein 4)levels more above 242 pmol/l vi. Pregnancy, breast feeding vii. Cases with other systemic diseases like cardiovascular, endocrine diseases or Systemic infections or on other treatment therapies. viii. Positive PAP SMEAR test reports indicating Cervical Carcinoma. ix. B.P more than 150/90 mm Hg x. Fasting Blood Sugar more than 150 mg/dl

Design outcomes

Primary

MeasureTime frame
To compare the relief in the symptoms of ovarian cyst along with reduction/ complete resolution in the size of the cyst evident through USG reports. To compare the changes in MYMOP2 and ORIDL Score. Timepoint: 6 months

Secondary

MeasureTime frame
To compare the changes in WHQ Score. To establish casual attribution of Homoeopathic treatment through MONARCH Score. To identify the prognostic factor of research (PFR) of effective medicines. Timepoint: 6 months

Countries

India

Contacts

Public ContactDr Padmalaya Rath

Central Council for Research in Homoeopathy

drpadmalaya@gmail.com9811704560

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026